pCMVβ lacZco
Vector

Overview:
This high copy
number eukaryotic vector, pCMVb expresses the full-length codon-optimized b-galactosidase gene (lacZco) under
the control of the cytomegalovirus immediate early gene (CMV IE) promoter. When expressed in mammalian cells, the
codon-optimized gene results in expression levels of β-galactosidase
15-fold higher than those resulting from an analogous construct containing the
native E. coli gene sequence.
Enhanced transcript stability and increased translational efficiency
provide for increased β-galactosidase expression, as suggested by RNA
analysis. In addition,
codon-optimization results in the elimination of several cryptic splice
acceptor sites that are present in the native E. coli gene sequence and
increases the amounts of un-spliced, full-length genomic RNA when used in a
lentiviral vector containing a 5’ splice donor.1 The b-galactosidase enzyme expression is also enhanced
by the SV40 late polyadenylylation signal.
This pCMVb expression vector contains the b-lactamase gene, which acts as a selection
marker (100mg/mL ampicillin resistance) in E. coli host. pCMVb vector has been tested to generate up to
2530u/mg cell extract (MacGregor, and Caskey).
If desired, the b-galactosidase codon optimized gene can be
excised using XhoI and NotI sites to allow the insertion of other
genes to be expressed under the same regulatory elements in mammalian
cells. See also our pSV40b lacZco vector system, Product M1016.
Price: 20mg $204.75 (USD)
References: